Matthew P. Young, EVP & CFO at Jazz Pharmaceuticals plc (JAZZ), sold 3,682 shares at $164.64 ($607K) on 2018-05-15, disclosed to the SEC on 2018-05-16.
Seasonal sale ($607k) by EVP & CFO — this insider has traded JAZZ in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $166.00 | 842 | $140K | 23.0% |
| 2 | $164.64 | 1,420 | $234K | 38.5% |
| 3 | $164.64 | 1,420 | $234K | 38.5% |
| Total | $164.95 avg | 3,682 | $607K | 100% |
| Filing → |
| JAZZ | SELL | 2018-11-27 | $105K | — | Filing → |
| JAZZ | SELL | 2018-10-17 | $221K | — | Filing → |
| JAZZ | SELL | 2018-09-19 | $228K | — | Filing → |